2 results
Approved WMOCompleted
The purpose of this study is to see if Daratumumab is useful for treating patients with relapsed or refractory Mantle Cell Lymphoma (MCL), Diffuse Large B-Cell Lymphoma (DLBCL), or Follicular Lymphoma (FL). Another purpose of the study is to see if…
Approved WMOCompleted
Evaluation of the effect of daratumumab in combination with ATRA in patients with relapsed/refractory multiple myeloma